Over three days, from 2 to 4 December, leading experts in the cell process par excellence, namely, protein translation, and specialists in associated diseases will come together at the IEC on the occasion of an event held by the Institute for Research in Biomedicine (IRB Barcelona) and the BBVA Foundation. Lluís Ribas de Pouplana, ICREA researcher at IRB Barcelona –based in the PCB–, and Peter Dedon, from the Massachusetts Institute of Technology (MIT, USA), are the chairs of the 23rd Barcelona Biomed Conference, "Gene translation: fidelity and quality control".

”

Molecular biology, the most important scientific revolution of the 20th century, focuses on the most vital cell process, namely protein synthesis. It is the process through which genetic material is used by the cell to produce proteins, the molecules responsible for almost all cellular functions. “Because protein synthesis is such a key process, the list of physiological disorders caused by errors during translation and control is enormous,” explains Ribas de Pouplana, head of the Gene Translation Laboratory.

In this Barcelona Biomed Conference, Drs. Ribas and Dedon have brought together researchers from labs that have been working in gene translation for more than forty years and scientists working in distant biomedical topics who have found a link between their fields and translation. “This is a very commixed conference because, surprisingly, this dialogue is not common. The success of the conference, the International profiles of the participants that we have attracted and the presence of Eric Westhof, chief editor of the top journal in this field, Nucleic Acids Research, reflects that the organisation of this conference was spot on,” says Ribas.

For further information [+]</a